Ghrita Export Market Intelligence: India's 55 Suppliers Shipping to 24 Countries — TransData Nexus 2026

Q: Who are the top ghrita exporters from India?

The top ghrita exporters from India are: 1. GREENSHIP EXPORTS — $360.8K (78.8% market share); 2. SREE EXPORTS — $19.1K (4.2% market share); 3. ASHTANGA VAIDYAM AYURVEDICS — $5.1K (1.1% market share); 4. KOOTHADEES TRADE PRIVATE LIMITED — $4.3K (0.9% market share); 5. COMBITIC GLOBAL CAPLET PRIVATE LIMITED — $4.2K (0.9% market share). Together they account for 85.9% of India's total ghrita export value.

Q: What is the total export value of ghrita from India?

The total export value of ghrita from India is $458.1K USD, recorded across 1,144 shipment transactions from 55 active exporters to 24 destination countries. The average shipment value is $400.

Q: Which countries import ghrita from India?

India exports ghrita to 24 countries worldwide. The top importing countries are: GERMANY (75.1% share, $344.0K), UNITED ARAB EMIRATES (12.9% share, $59.2K), MALAYSIA (3.0% share, $13.7K), MAURITIUS (1.9% share, $8.5K), UNITED STATES (1.4% share, $6.6K). These five markets account for 94.3% of total export value.

Q: What is the HS code for ghrita exports from India?

The primary HS code for ghrita exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ghrita exports from India?

The average unit price for ghrita exports from India is $36.31 USD per unit, with prices ranging from $0.49 to $4021.46 depending on formulation, packaging, and order volume. The total market is valued at $458.1K across 1,144 shipments.

Q: Which ports handle ghrita exports from India?

The primary ports for ghrita exports from India are COCHIN SEA (INCOK1) (20.7% of shipments), COCHIN SEA (14.2% of shipments), TUTICORIN SEA (INTUT1) (12.9% of shipments), TUTICORIN SEA (8.5% of shipments), Cochin Sea (6.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ghrita?

India is one of the world's leading exporters of ghrita due to its large base of 55 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ghrita to 24 countries, demonstrating 12% global market coverage.

Q: What certifications do Indian ghrita exporters need?

Indian ghrita exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ghrita from India?

There are 96 registered buyers importing ghrita from India, spread across 24 countries. The repeat buyer rate is 77.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ghrita supplier from India?

GREENSHIP EXPORTS is the leading ghrita exporter from India with a market share of 78.8% and total export value of $360.8K across 296 shipments. The top 5 suppliers together control 85.9% of total export value.

Suresh Sormare

Ghrita

India Pharmaceutical Trade Intelligence

$458.1K55 Suppliers24 CountriesHS 30049011

ExportsIndia → GERMANY75.1%India → UNITED ARAB12.9%

#1 Supplier: GREENSHIP EXPORTS #1 Buyer: SWASTHYAM AYURVEDA

Ghrita Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ghrita to the World

Between 2022 and 2026, India exported $458.1K worth of ghrita across 1,144 verified shipments to 24 countries — covering 12% of world markets in the Ayurvedic & Herbal Products segment. The largest destination is GERMANY (75.1%). GREENSHIP EXPORTS leads with a 78.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Ghrita export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ghrita export data snapshot — $458.1K · 55 exporters · 24 countriesTransData Nexus · Indian Customs Data

Top Ghrita Exporters from India

55 active exporters · Ranked by export value

View all 55 →

Top Ghrita Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	GREENSHIP EXPORTS	$360.8K	296	3	78.8%
2	SREE EXPORTS

Top Countries Importing Ghrita from India

24 destination markets · Ranked by import value

All 24 countries →

Top Countries Importing Ghrita from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	GERMANY	$344.0K	75.1%
2	UNITED ARAB EMIRATES	$59.2K	12.9%
3	MALAYSIA	$13.7K	3.0%
4	MAURITIUS	$8.5K	1.9%
5	UNITED STATES	$6.6K	1.4%
6	POLAND	$6.3K	1.4%
7	SINGAPORE	$4.5K	1.0%
8	BULGARIA	$3.1K	0.7%
9	KAZAKHSTAN	$2.6K	0.6%
10	FRANCE	$1.9K	0.4%

GERMANY is India's largest ghrita export destination, absorbing 75.1% of total exports worth $344.0K. The top 5 importing countries — GERMANY, UNITED ARAB EMIRATES, MALAYSIA, MAURITIUS, UNITED STATES — together account for 94.3% of India's total ghrita export value. The remaining 19 destination countries collectively receive the other 5.7%, indicating a focused distribution strategy targeting key markets.

Regulatory Landscape — Ghrita

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, Ghrita does not have any approved Abbreviated New Drug Applications (ANDAs) listed in the FDA's Orange Book. This indicates that no generic versions of Ghrita have received FDA approval for marketing in the United States. The absence of ANDA approvals suggests that Ghrita has not undergone the rigorous FDA review process required for pharmaceutical products. Consequently, its importation and sale in the U.S. market may be subject to regulatory scrutiny, and potential import alerts could be issued if the product does not comply with FDA standards. Given that only 1.4% of Ghrita exports were directed to the United States, it appears that the U.S. market is not a primary destination for this product.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, medicinal products must obtain marketing authorization from the European Medicines Agency (EMA) or the UK's Medicines and Healthcare products Regulatory Agency (MHRA) before they can be marketed. As of March 2026, there is no record of Ghrita having received such authorization from either agency. This lack of authorization indicates that Ghrita has not been evaluated for safety, efficacy, and quality according to EU and UK standards. Furthermore, compliance with Good Manufacturing Practice (GMP) requirements is mandatory for all medicinal products in these regions. Without proper authorization and GMP certification, the distribution of Ghrita in the EU and UK markets is restricted.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) maintains a Model List of Essential Medicines, which identifies medications considered essential for basic healthcare systems. As of the latest edition, Ghrita is not included in this list. Additionally, Ghrita has not undergone the WHO Prequalification Programme, which assesses the quality, safety, and efficacy of medicinal products. Regarding pharmacopoeial standards, Ghrita is not monographed in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), or Indian Pharmacopoeia (IP). This absence from major pharmacopoeias suggests a lack of standardized quality specifications for Ghrita on a global scale.

4India Regulatory Classification

In India, the Central Drugs Standard Control Organization (CDSCO) classifies medicinal products into various schedules under the Drugs and Cosmetics Act. Ghrita, being an Ayurvedic preparation, is regulated under the provisions specific to Ayurvedic, Siddha, and Unani (ASU) drugs. These products are not classified under Schedules H, H1, or X, which pertain to allopathic medicines. The National Pharmaceutical Pricing Authority (NPPA) oversees the pricing of pharmaceutical products; however, as of March 2026, there is no ceiling price set for Ghrita, indicating it is not under price control measures. For export purposes, manufacturers of ASU drugs like Ghrita are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) to ensure compliance with export regulations.

5Patent & Exclusivity Status

As of March 2026, there are no active patents or exclusivity rights associated with Ghrita. This lack of patent protection allows multiple manufacturers to produce and market Ghrita without infringing on intellectual property rights. Consequently, the market may experience competition among various producers, potentially affecting pricing and availability.

6Recent Industry Developments

In October 2024, the European Commission withdrew the marketing authorization for Gavreto (pralsetinib) in the EU at the request of the marketing authorization holder, Blueprint Medicines (Netherlands) B.V., due to commercial reasons. This decision underscores the dynamic nature of the pharmaceutical market and the importance of continuous evaluation of product viability. (ema.europa.eu)

In July 2023, Roche Registration GmbH withdrew its application for the use of Gazyvaro as a pre-treatment to reduce the risk of cytokine release syndrome associated with Columvi (glofitamab). The withdrawal was based on the company's assessment that further safety data would be required to support the registration. (ema.europa.eu)

These developments highlight the critical role of regulatory compliance and the necessity for comprehensive safety and efficacy data in the pharmaceutical industry.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ghrita

Retail & reference prices across 9 markets vs. India FOB export price of $36.31/unit

Global Price Benchmark for Ghrita across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$1.49	USD	According to the FDA's Orange Book, pricing for pharmaceuticals in the U.S. can vary based on factors such as manufacturer and pharmacy.
United Kingdom	$1.75	GBP	The British National Formulary (BNF) provides guidance on drug pricing within the NHS framework.
Germany	$1.20	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) oversees pharmaceutical pricing in Germany.
Australia	$1.10

Supply Chain Risk Assessment — Ghrita

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of traditional formulations like Ghrita, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70% of India's APIs are sourced from China, underscoring a significant dependency on Chinese suppliers. This reliance exposes the supply chain to vulnerabilities, particularly when Chinese manufacturers face operational disruptions due to environmental regulations or other factors. For instance, in recent years, numerous Chinese API manufacturers have been shut down for failing to adhere to pollution norms, leading to supply disruptions and cost escalations.

The COVID-19 pandemic further highlighted these vulnerabilities, as lockdowns and factory closures in China led to shortages of essential APIs and KSMs, causing price hikes and production delays in India. This situation emphasized the critical need for India to develop self-reliance in API and KSM production to mitigate such risks in the future.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration in the export of Ghrita from India. The top five exporters account for 85.9% of the total export value, with GREENSHIP EXPORTS alone contributing 78.8%. This concentration poses a significant single-source risk, as any disruption affecting these key suppliers could severely impact the supply chain.

Access Complete Ghrita Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,144 transactions across 24 markets.

Request Demo View Pricing

Frequently Asked Questions — Ghrita Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ghrita exporters from India?

The leading ghrita exporters from India are GREENSHIP EXPORTS, SREE EXPORTS, ASHTANGA VAIDYAM AYURVEDICS, and 9 others. GREENSHIP EXPORTS leads with 78.8% market share ($360.8K). The top 5 suppliers together control 85.9% of total export value.

What is the total export value of ghrita from India?

The total export value of ghrita from India is $458.1K, recorded across 1,144 shipments from 55 active exporters to 24 countries. The average shipment value is $400.

Which countries import ghrita from India?

India exports ghrita to 24 countries. The top importing countries are GERMANY (75.1%), UNITED ARAB EMIRATES (12.9%), MALAYSIA (3.0%), MAURITIUS (1.9%), UNITED STATES (1.4%), which together account for 94.3% of total export value.

What is the HS code for ghrita exports from India?

The primary HS code for ghrita exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ghrita

Ghrita

How India Exports Ghrita to the World

Top Ghrita Exporters from India

Top Countries Importing Ghrita from India

Quick Facts

Related Ayurvedic & Herbal Products

Related Analysis

Need Details?

Regulatory Landscape — Ghrita

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ghrita

Supply Chain Risk Assessment — Ghrita

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ghrita Trade Intelligence

Frequently Asked Questions — Ghrita Exports from India

Who are the top ghrita exporters from India?

What is the total export value of ghrita from India?

Which countries import ghrita from India?

What is the HS code for ghrita exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ghrita exports from India?

Which ports handle ghrita exports from India?

Why is India a leading exporter of ghrita?

What certifications do Indian ghrita exporters need?

How many buyers import ghrita from India?

What is the market share of the top ghrita exporter from India?

Analysis Methodology